Keywords: AVF; arteriovenous fistula; KDOQI; Kidney Disease Outcomes Quality Initiative; PCB; paclitaxel-coated balloon; PTA; percutaneous transluminal angioplasty;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AVF; arteriovenous fistula; BVT; basilic vein transposition; KDOQI; Kidney Disease Outcome Quality Initiative; s.c.; subcutaneous; US; ultrasonography; Basilic vein; Brachial artery; Minimally invasive; Fistula; Transposition;
Keywords: BMD; bone mineral density; BMI; body mass index; BMU; basic multicellular unit; CAV; cardiac allograft vasculopathy; CKD; chronic kidney disease; CS; corticosteroids; DXA; dual energy X-ray absorptiometry; FASL; FAS ligand; FRAX; Fracture Risk Assessment
Keywords: AR; access recirculation; AVF; arteriovenous fistula; AVG; arteriovenous graft; DHIS; distal hypoperfusion ischemia syndrome; KDOQI; Kidney Disease Outcomes Quality Initiative; NKF; National Kidney Foundation; Qa; blood access flow rate;
Keywords: AKI; acute kidney injury; AKIN; Acute Kidney Injury Network; CIN; contrast-induced nephropathy; CKD; chronic kidney disease; CT; computed tomographic; eGFR; estimated glomerular filtration rate; EMR; electronic medical record; KDOQI; Kidney Disease Outcom
Keywords: CVS; central venous stenosis; IVC; inferior vena cava; KDOQI; Kidney Dialysis Outcomes Quality Initiative; PTA; percutaneous transluminal angioplasty; SVC; superior vena cava;
Clinical StudyA Prospective, Randomized Study of an Expanded Polytetrafluoroethylene Stent Graft versus Balloon Angioplasty for In-Stent Restenosis in Arteriovenous Grafts and Fistulae: Two-Year Results of the RESCUE Study
Keywords: ACPP; access circuit primary patency; AV; arteriovenous; CEC; clinical events committee; CI; confidence interval; ePTFE; expanded polytetrafluoroethylene; HR; hazard ratio; IPF; index of patency function; ITT; intent-to-treat; KDOQI; Kidney Disease Outcom
Randomized Trial Comparing the Primary Patency following Cutting Versus High-Pressure Balloon Angioplasty for Treatment of de Novo Venous Stenoses in Hemodialysis Arteriovenous Fistulae
Keywords: AV; arteriovenous; KDOQI; Kidney Disease Outcomes Quality Initiative; RBP; rated burst pressure; RCT; randomized controlled trial;
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
Keywords: Hemodialysis; Clinical Practice Guideline; hemodialysis prescription; hemodialysis frequency; initiation; adequacy; treatment time; hemofiltration; urea modeling; evidence-based recommendation; KDOQI
Prevalence of vitamin D deficiency and consequences for PTH reference values
Keywords: NESDA; Netherlands Study of Depression and Anxiety; LASA; Longitudinal Aging Study Amsterdam; KDIGO; Kidney Disease: Improving Global Outcomes; KDOQI; National Kidney Foundation-Kidney Disease Outcomes Quality Initiative; CKD; Chronic Kidney Disease; CKD-
Diagnostic value of transferrin
Keywords: AASLD; American Association for the Study of Liver Diseases; CHD; Coronary heart disease; CI; Confidence interval; CKD; Chronic kidney disease; DM; Diabetes mellitus; EASL; European Association for the Study of the Liver; ESA; Erythropoiesis-stimulating a
Care of the Renal Patient in Radiology
Keywords: Radiology; Renal failure; Renal insufficiency; KDOQI; Fistula; GFR; CIN; Contrast induced nephropathy; Metabolic syndrome; Creatinine; Prevention; Nursing management
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
Keywords: Albuminuria; chronic kidney disease; Clinical Practice Guideline; diabetes; dyslipidemia; evidence-based recommendation; KDOQI;
Impact of Kidney Disease Outcomes Quality Initiative Guidelines on the Prevalence of Chronic Kidney Disease After Living Donor Nephrectomy
Keywords: kidney failure, chronic; living donors; nephrectomy; BMI; body mass index; CKD; chronic kidney disease; eGFR; estimated glomerular filtration rate; ESRD; end stage renal disease; GFR; glomerular filtration rate; HALDN; hand assisted laparoscopic donor nep
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes
Keywords: CKD; chronic kidney disease; ESRD; end-stage renal disease; CVD; cardiovascular disease; NKF; National Kidney Foundation; KDOQI; Kidney Disease Outcomes Quality Initiative; GFR; glomerular filtration rate; MDRD; Modification of Diet in Renal Disease; CKD-
Endpoints for Hemodialysis Access Procedures: Correlation between Fistulography and Intraaccess Blood Flow Measurements
Keywords: ABF; access blood flow; CI; confidence interval; KDOQI; Kidney Disease Outcomes Quality Initiative; UCSD; University of California San Diego;
L'essentiel des nouvelles recommandations des kidney disease: improving global outcomes (KDIGO) pour les désordres du métabolisme minéral et osseux à l'usage du clinicien francophone
Keywords: KDIGO; KDOQI; Métabolisme minéral et osseux; Insuffisance rénale; KDIGO; KDOQI; Mineral and bone disorders; Chronic kidney disease;
Parathyroid hormone measurement in CKD
Keywords: assay standardization; bone mineral metabolism; chronic kidney disease; KDOQI; parathyroid hormone; radioimmunoassay
Clinical utility of calcimimetics targeting the extracellular calcium-sensing receptor (CaSR)
Keywords: CaSR; calcium-sensing receptor; Cao2+; extracellular calcium concentration; PTH; parathyroid hormone; NKF; National Kidney Foundation; FDA; US Food and Drug Administration; CKD; chronic kidney disease; MGluR; metabotropic glutamate receptor; GABA; gamma a
KDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Keywords: Kidney transplant recipients (KTRs); calcineurin inhibitor (CNI); mycophenolate compound (MPA compound); inhibitor of mammalian target of rapamycin (mTOR inhibitor); KDIGO; KDOQI;
Dissecting and refining the staging of chronic kidney disease
Keywords: chronic kidney disease; definition and staging of CKD; KDOQI
Use of Erythropoiesis-Stimulating Agents in Patients With Anemia of Chronic Kidney Disease: Overcoming the Pharmacological and Pharmacoeconomic Limitations of Existing Therapies
Keywords: CHOIR; Correction of Hemoglobin and Outcomes in Renal Insufficiency; CKD; chronic kidney disease; CREATE; Cardiovascular Risk Reduction by Early Anemia Treatment with Epoetin Beta; ESA; erythropoiesis-stimulating agent; FDA; Food and Drug Administration;
Prevalence of complications in children with chronic kidney disease according to KDOQI
Keywords: KDOQI; chronic kidney disease; prevalence; complications; cystatin C; glomerular filtration rate